Cargando…
Therapeutic Challenges and Emerging Treatment Targets for Pulmonary Hypertension in Left Heart Disease
Pulmonary hypertension (PH) attributable to left heart disease (LHD) is believed to be the most common form of PH and is strongly associated with increased mortality and morbidity in this patient population. Specific therapies for PH‐LHD have not yet been identified and the use of pulmonary artery h...
Autores principales: | Lteif, Christelle, Ataya, Ali, Duarte, Julio D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8483544/ https://www.ncbi.nlm.nih.gov/pubmed/34032129 http://dx.doi.org/10.1161/JAHA.120.020633 |
Ejemplares similares
-
Pulmonary Hypertension in Mitral Regurgitation
por: Patel, Harsh, et al.
Publicado: (2014) -
Repurposing Medications for Treatment of Pulmonary Arterial Hypertension: What's Old Is New Again
por: Prins, Kurt W., et al.
Publicado: (2018) -
Purinergic Dysfunction in Pulmonary Arterial Hypertension
por: Cai, Zongye, et al.
Publicado: (2020) -
Biomechanical and Mechanobiological Drivers of the Transition From PostCapillary Pulmonary Hypertension to Combined Pre−/PostCapillary Pulmonary Hypertension
por: Allen, Betty J., et al.
Publicado: (2023) -
The Role of Regulatory T Cells in Pulmonary Arterial Hypertension
por: Qiu, Haihua, et al.
Publicado: (2019)